CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The StealthStent project develops a resorbable stent specifically designed for children with congenital heart diseases. This innovative stent dissolves over time, allowing for natural vessel growth and reducing complications associated with traditional stents.
Congenital Heart Diseases (CHD) are the most common type of birth defect, affecting more than 1,400,000 newborns annually.
About 40% of these children need a stent treatment before they are fully grown, however there is no specific treatment for pediatric patients.
The current standard of care is the off-label use of permanent stents designed for adults which is heavily affected by Foreign Body Reaction (FBR), stent migration and breakage.
This leads to a high risk of patient mismatch, severe ad…
BIOMODICS APS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Berlin
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
